Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of the Osteoporosis Self-Assessment Tool (OST) and Osteoporosis Risk Assessment Index (ORAI) in Predicting Osteoporosis in Postmenopausal Turkish Women

NCT07402772 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.

NCT NCT07402772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of the Osteoporosis Self-Assessment Tool (OST) and Osteoporosis Risk Assessment Index (ORAI) in Predicting Osteoporosis in Postmenopausal Turkish Women
Lead sponsor
Kayseri City Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
February 4, 2026
Completion date
July 15, 2026
Enrollment
1,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

female osteoporosis